Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 383, Issue 2, Pages 109-119
Publisher
Massachusetts Medical Society
Online
2020-07-09
DOI
10.1056/nejmoa2003715

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.